BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2470655)

  • 1. Pars plana vitrectomy and silicone oil injection in proliferative diabetic retinopathy.
    Heimann K; Dahl B; Dimopoulos S; Lemmen KD
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(2):152-6. PubMed ID: 2470655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy.
    Douglas MJ; Scott IU; Flynn HW
    Ophthalmic Surg Lasers Imaging; 2003; 34(4):270-8. PubMed ID: 12875454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epiretinal membrane formation after pars plana vitrectomy in proliferative diabetic retinopathy].
    Messmer E; Bornfeld N; Oehlschläger U; Heinrich T; Foerster MH; Wessing A
    Klin Monbl Augenheilkd; 1992 Apr; 200(4):267-72. PubMed ID: 1614088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Does silicone oil improve the prognosis of severe proliferative diabetic retinopathy?].
    Gabel VP; Beck P
    Klin Monbl Augenheilkd; 1990 Aug; 197(2):112-7. PubMed ID: 2243469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment.
    Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
    Retina; 2008 Oct; 28(9):1201-6. PubMed ID: 18728620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy.
    Mason JO; Colagross CT; Haleman T; Fuller JJ; White MF; Feist RM; Emond TL; McGwin G
    Am J Ophthalmol; 2005 Aug; 140(2):231-5. PubMed ID: 15992755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Temporary silicone oil implantation following vitrectomy in proliferative diabetic retinopathy].
    Gnad H; Skorpik C; Paroussis P; Menapace R; Radda TM; Prskavec FH; Grasl M
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):388-90. PubMed ID: 2433498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy.
    Ghasemi Falavarjani K; Modarres M; Hadavandkhani A; Karimi Moghaddam A
    Eye (Lond); 2015 Sep; 29(9):1199-203. PubMed ID: 26160528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endotamponade with silicon oil in severe proliferative retinopathy with attached retina].
    Hoerauf H; Roider J; Bopp S; Lucke K; Laqua H
    Ophthalmologe; 1995 Oct; 92(5):657-62. PubMed ID: 8750991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the usefulness of vitrectomy in the treatment of proliferative diabetic retinopathy].
    Szymańska M
    Klin Oczna; 1992; 94(7-8):197-8. PubMed ID: 1300399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silicone oil for the treatment of severe proliferative diabetic retinopathy.
    Brourman ND; Blumenkranz MS; Cox MS; Trese MT
    Ophthalmology; 1989 Jun; 96(6):759-64. PubMed ID: 2472586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silicone oil for progressive anterior ocular neovascularization after failed diabetic vitrectomy.
    McCuen BW; Rinkoff JS
    Arch Ophthalmol; 1989 May; 107(5):677-82. PubMed ID: 2470339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute onset of rubeosis iridis after diabetic vitrectomy can indicate peripheral traction retinal detachment.
    Bopp S; Lucke K; Laqua H
    Ger J Ophthalmol; 1992; 1(6):375-81. PubMed ID: 1283355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Munir WM; Pulido JS; Sharma MC; Buerk BM
    Can J Ophthalmol; 2005 Oct; 40(5):598-604. PubMed ID: 16391623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vitrectomy and subsequent photocoagulation in proliferative diabetic retinopathy with vitreous hemorrhage].
    Gerke E; Alvira G
    Klin Monbl Augenheilkd; 1986 Jan; 188(1):5-8. PubMed ID: 2421045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrasilicone bevacizumab injection for iris neovascularization after vitrectomy for proliferative diabetic retinopathy.
    Salman AG
    Ophthalmic Res; 2013; 49(1):20-4. PubMed ID: 22986803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of pars plana vitrectomy and silicone oil for complications of diabetic retinopathy.
    Karel I; Kalvodová B
    Eur J Ophthalmol; 1994; 4(1):52-8. PubMed ID: 8019122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of complicated retinal detachment by vitrectomy and silicone oil injection.
    Ehud A; Varda C; Joseph M; Giora T
    Metab Pediatr Syst Ophthalmol (1985); 1988; 11(1-2):63-6. PubMed ID: 2475741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of intraocular tamponade in treatment of complications of proliferative diabetic retinopathy].
    Nawrocki J; Dziegielewski K; Pikulski Z
    Klin Oczna; 1993; 95(9-10):354-6. PubMed ID: 8022167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of vitrectomy without endotamponade in proliferative diabetic retinopathy with tractional retinal detachment.
    Tao Y; Jiang YR; Li XX; Gao L; Jonas JB
    Retina; 2010 Mar; 30(3):447-51. PubMed ID: 20216292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.